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Toxoplasma gondii proteome <p>A proteomics analysis identifies one third of the predicted <it>Toxoplasma gondii</it> proteins and integrates proteomics and genom- ics data to refine genome annotation. </p>
Abstract
Background: Although the genomes of many of the most important human and animal pathogens
have now been sequenced, our understanding of the actual proteins expressed by these genomes
and how well they predict protein sequence and expression is still deficient. We have used three
complementary approaches (two-dimensional electrophoresis, gel-liquid chromatography linked
tandem mass spectrometry and MudPIT) to analyze the proteome of Toxoplasma gondii, a parasite
of medical and veterinary significance, and have developed a public repository for these data within
ToxoDB, making for the first time proteomics data an integral part of this key genome resource.
Results: The draft genome for Toxoplasma predicts around 8,000 genes with varying degrees of
confidence. Our data demonstrate how proteomics can inform these predictions and help discover
new genes. We have identified nearly one-third (2,252) of all the predicted proteins, with 2,477
intron-spanning peptides providing supporting evidence for correct splice site annotation.
Functional predictions for each protein and key pathways were determined from the proteome.
Importantly, we show evidence for many proteins that match alternative gene models, or
previously unpredicted genes. For example, approximately 15% of peptides matched more
convincingly to alternative gene models. We also compared our data with existing transcriptional
data in which we highlight apparent discrepancies between gene transcription and protein
expression.
Conclusion:  Our data demonstrate the importance of protein data in expression profiling
experiments and highlight the necessity of integrating proteomic with genomic data so that iterative
refinements of both annotation and expression models are possible.
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Background
Toxoplasma gondii is an obligate intracellular protozoan par-
asite that infects a wide range of animals, including humans.
It is a member of the phylum Apicomplexa, which includes
parasites of considerable clinical relevance, such as Plasmo-
dium, the causative agent of malaria, as well as important vet-
erinary parasites, such as Theileria, Eimeria, Neospora and
Cryptosporidium, some of which like Toxoplasma  are
zoonotic. In common with the other Apicomplexa, T. gondii
has a complex life-cycle with multiple life-stages. The asexual
cycle can occur in almost any warm-blooded animal and is
characterized by the establishment of a chronic infection in
which fast dividing invasive tachyzoites differentiate into
bradyzoites that persist within the host tissues. Ingestion of
bradyzoites via consumption of raw infected meat is an
important transmission route of Toxoplasma. By contrast,
the sexual cycle, which results in the excretion of infectious
oocysts in feces, takes place exclusively in felines.
The genome of Toxoplasma has been sequenced, with draft
genomes of three strains of Toxoplasma (ME49, GT1, VEG)
as well as chromosomes Ia and Ib of the RH strain available
via ToxoDB [1]. ToxoDB is a functional genomic database for
T. gondii that incorporates sequence and annotation data and
is integrated with other genomic-scale data, including com-
munity annotation, expressed sequence tags (ESTs) and gene
expression data. It is a component site of ApiDB, the Apicom-
plexan Bioinformatics Resource Center, which provides a
common research platform to facilitate data access among
this important group of organisms [2]. ToxoDB reflects pio-
neering efforts that have been made toward the annotation of
the Toxoplasma genome. Nevertheless, although the assem-
bly and annotation of the Toxoplasma  genome is far in
advance of most other eukaryotic pathogens, significant defi-
ciencies still remain; in common with many other genome
projects, annotation has thus far not taken into account infor-
mation provided by global protein expression data and nei-
ther have these data been available to the user community in
the context of other genome resources.
There is now an abundance of transcriptional expression data
for Toxoplasma, including expression profiling of the three
archetypal lineages of T. gondii. Transcriptional studies have
also provided evidence for stage-specific expression via EST
libraries, microarray analysis and SAGE (serial analysis of
gene expression) [3-6]. Clusters of developmentally regulated
genes, dispersed throughout the genome, have been identi-
fied that vary in both temporal and relative abundance, some
of which may be key to the induction of differentiation [4,6].
Global mRNA analysis indicates that gene expression is
highly dynamic and stage-specific rather than constitutive
[6]. However, the study of individual proteins has also impli-
cated the involvement of both post-transcriptional and trans-
lational control [7-9] and the potential regulation of ribosome
expression has also been proposed [10]. Evidence may also
point to possible epigenetic control of gene expression, fol-
lowing observations of a strong correlation between regions
of histone modification and active promoters [11,12].
Until now the study of global gene expression in T. gondii and
the use of expression data to inform gene annotation has been
almost exclusively confined to transcriptional analyses.
Whilst a relatively small number of proteins have been stud-
ied in considerable detail, published proteomic expression
data are limited to small studies employing two-dimensional
electrophoresis (2-DE) separation of tachyzoite proteins
[13,14], or to specific analysis of Toxoplasma sub-proteomes
that have been implicated in the invasion and establishment
of the parasite within the host cell [15-18].
This paper reports the first multi-platform global proteome
analysis of Toxoplasma tachyzoites resulting in the identifi-
cation of nearly one-third of the entire predicted proteome of
T. gondii and represents a significant advance in our under-
standing of protein expression in this important pathogen.
We describe also the development of a proteomics platform
within ToxoDB to act as a public repository for these, and
other, proteomic datasets for T. gondii. Our data are now
available as a public resource and add a vital hitherto missing
dimension to the expression data within ToxoDB. Moreover,
the addition of detailed protein expression information
within an integrated genomic platform highlights the value of
protein expression data not only in interpreting transcrip-
tional data (both ESTs and microarray data), but also pro-
vides valuable insights into the annotation of the genome of T.
gondii.
Results
Two-dimensional electrophoresis proteome map of T. 
gondii tachyzoites
Urea-soluble lysates from cultured T. gondii tachyzoites were
resolved using broad (pH 3-10) and narrow (pH 4-7) range 2-
DE gels (Figures 1 and 2; Additional data files 1 and 2). The
protein identity of individual protein spots was obtained
using electrospray mass spectrometry (Additional data files 3
and 4). In total, 1,217 individual protein spots were identified
by 2-DE analysis, 783 detected by the pH 3-10 separation and
434 by the pH 4-7 separation. In many instances proteins
from separate spots shared the same identity. Examples of
clusters of proteins with the same identification are shown
boxed in Figures 1 and 2, and these most likely represent
isoenzymes, or proteins with post-translational modification.
Many gel plugs contained more than one protein and this is
represented by overlapping boxes in the figures. Accounting
for redundancy between gels and assuming post-translational
variants are the products of a single gene, these data repre-
sent the expression of 616 non-redundant Toxoplasma genes,
of which 547 correspond to release4 gene annotation and 69
are described by alternative gene models or open reading
frames (ORFs) that do not correspond to a release4 annota-
tion (discussed further in the 'Genome annotation' sectionhttp://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.3
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below). Forty release4 genes (which exhibited a range of
masses, isoelectric points and functional annotations) were
uniquely identified using 2-DE analysis; that is, they were not
detected by either the gel liquid chromatography (LC)-linked
tandem mass spectrometry (MS/MS) or multidimensional
protein identification technology (MudPIT) approaches
described in the following sections.
T. gondii tachyzoite proteome analysis by one-
dimensional electrophoresis gel LC MS/MS
Whole tachyzoite protein, solubilized in SDS, was resolved
using a large format one-dimensional electrophoresis (1-DE)
gel (Figure 3). We excised 129 contiguous gel slices from the
entire length of the resolving gel and each gel slice was sub-
mitted to LC-MS/MS. This approach combines the resolving
power of SDS gel-based protein separation with that of the
2-DE proteome map (pH 3-10) of T. gondii tachyzoite proteins Figure 1
2-DE proteome map (pH 3-10) of T. gondii tachyzoite proteins. Protein spots were visualized using colloidal Coomassie. Spots with the same protein 
identification are boxed (for detailed numbering, see Additional data file 1). Abbreviations: G1/S phase, G1 to S phase transition protein; Arm RP, 
armadillo/beta catenin-like repeat containing protein; MLC1, mysosin light chain 1; Sec62, translocation protein Sec62; adenyl cyclase AP, adenyl cyclase 
associated protein; NPACa, nascent polypeptide associated complex, alpha chain; RBP, RNA binding protein; PKC IC thioredoxin, PKC interacting cousin 
of thioredoxin; TC tumour protein, translationally controlled tumour protein; BHSP, bradyzoite specific small heat shock protein; Mam33, mitochondrial 
acidic protein mam33; MSA p30, major surface antigen p30; MDH, malate dehydrogenase; gbp1p protein, gbp1p protein (RNA binding protein); P-serine 
AT, phosphoserine aminotransferase; inosine-5'-P DH, inosine-5'-monophosphate dehydrogenase; RNA recognition, RNA recognition motif containing 
protein; nucleolin, nucleolar phosphoprotein (nucleolin), putative; SCR protein, sushi domain-containing protein/SCR repeat-containing protein; 
nucleosome AP, nucleosome assembly related protein; M2AP, MIC2 associated protein; Rhp23, UV excision repair protein rhp23; PPIase, peptidyl prolyl 
isomerase; S/T phosphatase 2C, serine/threonine phosphatase 2C; vATPase F, vacuolar ATP synthase subunit F; splicing factor 3b/10, splicing factor 3b 
subunit 10; 40S RP S12, 40S ribosomal protein S12; eTIF1a, eukaryote translation initiation factor 1 alpha; eTIF3d, eukaryote translation initiation factor 3 
delta subunit; PPIPK, phosphatidylinositol-4-phosphate 5-kinase; LDH, lactate dehydrogenase; RACK, receptor for activated C kinase; LGL, 
lactoylglutathione lyase; Ca2+ BP, membrane associated calcium binding protein; IPP2A, inhibitor 1 or protein phosphatase type 2A; HPPK/DHPS, 
hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase; RNA BP, RNA binding motif protein; La protein, La domain containing 
protein; Pfs77r, pfs77 related protein; P-protein, phosphoprotein; PPI/WD, protein with peptidylprolyl isomerase domain and WD repeat; dUTP 
hydrolase, deoxyuridine 5'-triphosphate nucleotidohydrolase; PRE3, proteasome component PRE3 precursor; 10 kDa HSP mito, mitochondrial heat shock 
protein; PPIase NIMA, peptidyl-prolyl cis-trans isomerase NIMA-interacting 1; CEP52 fusion protein, ubiquitin/ribosomal protein CEP52 fusion protein.
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liquid chromatography separation coupled on-line to the
mass spectrometer and resulted in the generation of large,
high quality datasets of SDS-soluble proteins. An average of
20 proteins was identified from each 1 mm gel slice and the
complete dataset comprising 2,778 individual protein identi-
fications is shown in Additional data file 5. A further 1-DE
experiment, using prior Tris solubilization, led to the identifi-
cation of 82 additional release4 genes and 9 alternative gene
models (Additional data files 6 and 7). Some proteins were
identified in multiple gel slices again, likely due to isozymes
or post-translational modifications. When redundancy
between proteins with the same identification was removed,
1,012 individual gene products (939 release4 and 73 alterna-
tive gene models) were identified from T. gondii tachyzoites
by gel LC-MS/MS analysis (Additional data files 8 and 9).
MudPIT analysis of T. gondii tachyzoites
Whole tachyzoite protein was partitioned into Tris-soluble
and Tris-insoluble fractions, and each processed for MudPIT
analysis; this resulted in 1,300 and 2,328 protein identifica-
tions, respectively, and a total non-redundant dataset com-
prising 2,409 proteins, which comprises 2,121 release4 and
288 alternative gene models (Additional data files 10 and 11).
Of the release4 genes identified, 15.3% were identified
uniquely in the Tris-soluble fraction and 48.0% were identi-
fied uniquely in the Tris-insoluble fraction.
When the results using all three proteomic platforms were
combined, a total of 2,252 non-redundant release4 protein
identifications were obtained from the tachyzoite stage of the
parasite. This represents expression from approximately 29%
2-DE proteome map (pH 4-7) of T. gondii tachyzoite proteins Figure 2
2-DE proteome map (pH 4-7) of T. gondii tachyzoite proteins. Protein spots were visualized using colloidal Coomassie. Spots with the same protein 
identification are boxed (for detailed numbering, see Additional data file 2). Abbreviations (also refer to Figure 1): PSAT, phosphoserine amino transferase; 
IF4E, translation initiation factor 4E; BCDC E1, branched-chain alpha-keto acid dehydrogenase; SOD, superoxide dismutase; OGDC E2, dihydrolipoamide 
succinyltransferase component of 2-oxoglutaratedehydrogenase complex; EGF1b, elongation factor 1 beta; ubiquitin-E2, ubiquitin-conjugating enzyme E2; 
F-1,6 bisP aldolase, fructose, 1,6 bis phosphate aldolase; PGK, phosphoglycerate kinase; F1,6 b Pase, fructose 1,6 bis phosphatase; U5 snRNP, U5 snRNP-
specific 40 kDa protein (hPrp8-binding); Dihydrolipoyl DH, Dihydrolipoyl dehydrogenase, third enzyme of PDC, OGDC, BCDC.
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of the total number of currently predicted release4 genes. Fig-
ure 4 illustrates the degree of overlap between the datasets
derived using each of the three proteomic platforms. MudPIT
generated the largest number of identifications; however, a
number of proteins were uniquely identified using the gel-
based approaches (59 for 1-DE; 40 for 2-DE). Other studies
have also highlighted the benefits of a multi-platform pro-
teomic approach and the advantages and disadvantages of
each platform have been discussed extensively elsewhere
[19]. Notably, the gel-based proteomic platforms detected, on
average, more peptides per protein identification than Mud-
PIT. Overall across all platforms, only approximately 6% of
the 2,252 proteins identified were based on single peptide evi-
dence; this represents a relatively low proportion compared
to other apicomplexan proteomic studies [19-21] and is prob-
ably accounted for partly by the extensive data from gel-based
proteomics in addition to the MudPIT analysis. In addition to
the release4 genes, 394 non-redundant alternative gene mod-
els and ORFs were also identified from the entire dataset.
These data represent sets of peptides that map more compre-
hensively to alternative models and ORFs than the release4
gene models, and have considerable implications for genome
annotation, as discussed below.
Functional analyses and key pathways of the tachyzoite 
proteome
Each individual protein detected by proteomics was submit-
ted to the motif prediction algorithms SignalP [22] and
TMHMM [23] and also to subcellular localization prediction
programs, for example, PATS (apicoplast) [24], PlasMit
(mitochondrion) [25], WoLF PSORT (general) [26] and Gene
Ontology (GO) cellular component prediction downloaded
from ToxoDB. Toxoplasma genome predictions suggest that
11% of proteins contain a signal peptide and 18% contain
transmembrane domains (information available at ToxoDB).
Virtually identical proportions were detected in this study in
the expressed proteome of tachyzoites (10% and 18%, respec-
tively). Analysis of the 394 alternative gene models and ORFs
gave closely similar proportions (results not shown). This
Tachyzoite proteins resolved for 1-DE gel LC-MS/MS Figure 3
Tachyzoite proteins resolved for 1-DE gel LC-MS/MS. SDS-soluble 
proteins from 1.1 × 108 tachyzoites were resolved on a 12% (w/v) 
acrylamide gel under denaturing conditions as follows: protein standards 
(lane 1); T. gondii soluble protein (lane 3). Proteins were visualized using 
colloidal Coomassie stain.
kDa
250
150
100
75
50
25
37
20
15
1
10
20
30
40
50
60
70
80
90
100
110
120
129
5
15
25
35
45
55
65
75
85
95
105
115
125
The tachyzoite expressed proteome: comparison of proteome strategies Figure 4
The tachyzoite expressed proteome: comparison of proteome strategies. 
Venn diagram showing the numbers of unique and shared non-redundant 
release4 gene identifications obtained from each of the three proteomics 
platforms.
59
MudPIT
1-DE
2-DE
40
1169
104
32
371
477Genome Biology 2008, 9:R116
http://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.6
represents expression of more than one-quarter of the pre-
dicted numbers of membrane and secreted proteins within
one life-cycle stage of the parasite. Assuming non-biased
sampling, these results imply no enrichment for membrane
proteins in tachyzoites. Similar proportions of signal peptide
and transmembrane containing proteins were observed in the
expressed proteome of Plasmodium falciparum [20]. The
Toxoplasma proteins showed a wide distribution of sub-cel-
lular localizations, demonstrating broad sampling, with cyto-
plasmic, nuclear and mitochondrial locations well
represented (Figure 5a; Additional data file 12). Many pro-
teins were also potentially involved in secretory pathways and
were assigned to the endoplasmic reticulum-Golgi, the
plasma membrane and extracellular locations.
The functional analysis of the expressed proteome presented
in Figure 5b (see also Additional data file 13) was constructed
using the GO classifications listed on ToxoDB, which are
largely based on bioinformatics interpretation. Each release4
gene was then assigned to a specific Munich Information Cen-
tre for Protein Identification (MIPS) category within the Fun-
CatDB functional catalogue [27]. Some genes are without a
GO classification and were assigned a putative MIPS category
using additional information provided by Blast similarities,
Pfam domain alignments [28], InterPro [29], orthologs, Tox-
oplasma paralogs, and from independent literature searches.
Functional categories that are highly represented are metab-
olism, protein fate, protein synthesis, cellular transport, tran-
scription and proteins with binding functions. A large
proportion (36%) of the proteins have 'unknown function',
indicating the difficulty of obtaining functional information
using sequence similarity methods alone. Functional assign-
ments were also constructed for hits to alternative gene mod-
els and ORFs, revealing similar relative proportions of
functional categories, except for a larger proportion (70%) of
proteins with unknown function, presumably due to the
sequences being atypical, or incompletely predicted (Addi-
tional data file 14). The implications of the functional catego-
ries discovered are examined in the Discussion.
Tachyzoites are thought to rely upon both glycolysis and the
tricarboxylic acid cycle, unlike the bradyzoites, which are
thought to be largely dependent upon glycolysis [7]. Virtually
every component of the glycolysis/gluconeogenesis pathway
predicted for Toxoplasma was identified as being expressed
in tachyzoites by proteomic analysis, as illustrated in Figure
6. Additionally, considerable coverage of the oxidative phos-
phorylation and tricarboxylic acid cycle pathways was also
identified from the expressed proteome dataset (data not
shown; see ToxoDB for further details). Several enzymes of
the glycolytic pathway have been shown to be modulated dur-
ing differentiation [6,7], with some showing stage-specific
isoforms, such as enolase and lactate dehydrogenase [8]. The
level of mRNA expression does not always mirror that of the
expressed protein, indicating a degree of translational control
or changes in mRNA stability [8]. However, it should be
noted that detecting low levels of protein can be problematic.
One example is glucose-6-phosphate isomerase
(76.m00001). Western analysis detected expressed protein in
bradyzoites but not tachyzoites despite the presence of abun-
dant mRNA transcripts in both stages [30]. However, glu-
cose-6-phosphate isomerase was successfully detected in
tachyzoites in this whole cell proteome analysis (Additional
data file 5, gel slices 40-42), again illustrating the sensitivity
of our proteome approach.
Comparison with EST expression data
Figure 7a illustrates the degree of correlation between
release4 genes for which EST expression data are available
and genes for which the total proteome dataset identified in
this study has provided evidence of expression. By including
all the tachyzoite and bradyzoite cDNA evidence from RH,
ME49, VEG, CAST, COUG and MAS strains (available at Tox-
oDB), most (91%) of the proteins found in this study were
corroborated by EST data. Approximately half of these were
confirmed in both bradyzoite and tachyzoite stages by EST
analysis, suggesting that many of the proteins may have com-
mon, house-keeping functions. Although the EST coverage of
the total number of release4 genes listed at ToxoDB is rela-
tively high (68% for tachyzoite ESTs alone), for 266 release4
genes detected in this study using proteomics there was no
corresponding tachyzoite EST evidence, apparently reflecting
inadequacies in the coverage of the EST data. The distribution
of cellular functions amongst these 266 expressed proteins is
representative of the entire proteome dataset, indicating that
EST evidence is lacking for many different proteins and not
specific for a particular type or category of function (data not
shown).
Conversely, comparison of RH strain-specific tachyzoite ESTs
with the proteome dataset revea l e d  t h a t  5 7 %  o f  g e n e s  f o r
which there was EST transcript evidence were not corrobo-
rated by the detection of expressed protein in this study. This
is likely to be explained by a number of contributing factors,
including the difficulty in detecting low copy number,
transient and unstable proteins. It is also possible that a small
number of non-coding ESTs are present in the database for
which no protein product would be expected.
Comparison with microarray data
Microarray analysis of the RH strain of T. gondii has been
performed previously (data available through ToxoDB; A
Bahl and DS Roos unpublished). The analysis provides exten-
sive coverage of the genome (99.5% of release4 genes were
assayed), and the results have been cross-referenced with the
proteins identified. As it is difficult to determine the correct
signal:noise ratio above which mRNA levels can be consid-
ered to be indicative of a gene being switched on (all genes
represented on the array exhibit some signal, yet not all are
expressed), the microarray results were divided into quartiles
of mRNA expression level for the purposes of this compari-
son. Those genes in the bottom 25% were described as zerohttp://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.7
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Subcellular localisatonal categorization of the expressed tachyzoite proteome Figure 5
Subcellular localisation and functional categorization of the expressed tachyzoite proteome. The numbers correspond to the total number of identified 
proteins in each category. (a) Protein subcellular localization information was first assigned according to gene descriptions and GO annotation provided by 
ToxoDB. When no information was available, protein sequences were submitted to PATS, PlasMit and WoLF PSORT. The combined results were 
manually assessed to obtain subcellular localization predictions. A detailed list of proteins in each subcellular localization to accompany this figure is 
provided in Additional data file 12. (b) Functional categorization was constructed using the GO classifications listed on ToxoDB for each release4 gene, 
which were then assigned to specific MIPS categories within the FunCatDB functional catalogue. Genes without a GO classification were assigned a 
putative MIPS category using additional information provided by Blast, Pfam domain alignments, InterPro and from independent literature searches. Notes: 
protein fate includes protein folding, modification and destination. A detailed list of proteins in each functional category to accompany this figure is 
provided in Additional data file 13.
(a)
(b)Genome Biology 2008, 9:R116
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Metabolic pathway coverage: glycolysis/gluconeogenesis Figure 6
Metabolic pathway coverage: glycolysis/gluconeogenesis. Component enzymes of the glycolysis/gluconeogenesis pathways predicted to be present in 
Toxoplasma from genome analysis are colored. Virtually every component of the glycolysis/gluconeogenesis pathway predicted for Toxoplasma was 
identified as being expressed in tachyzoites by proteomic analysis. Green and blue indicate genes for which expression has been confirmed in tachyzoites 
in this study by mass spectrometric data; blue also signifies genes for which post-translational modification is likely as indicated by the evidence from two-
dimensional gels. Red indicates genes for which expression of predicted components has not been confirmed in this study. Coverage of key metabolic 
pathway component proteins was determined using the Metabolic Pathway Reconstruction for T. gondii available on the KEGG Pathway site accessed via 
ToxoDB [53].
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detectable mRNA above baseline, and alternatively those in
the bottom 50% were described as having zero or low detect-
able mRNA level. The Venn diagrams in Figure 7b illustrate
the degree of overlap between release4 genes, for which ≥ 25
percentile and ≥ 50 percentile mRNA expression was detected
by microarray analysis, and the genes identified by our pro-
teomic study. The results illustrate that some genes with zero
or low mRNA can still be identified in a proteome study (204
proteins matching the < 25% group and 632 proteins match-
ing the < 50% group). The detection of these proteins is
intriguing and there may be several possible explanations.
For example, these proteins may be highly stable and do not
require new transcription for the protein to be detected, or
perhaps substantial quantities of protein can be produced
from very low mRNA. Three examples from this group are:
'bi-functional aminoacyl-tRNA synthetase, putative/prolyl-
tRNA synthetase, putative' (38.m00021, 254 peptide hits),
'clathrin heavy chain, putative' (80.m02298, 148 peptide
hits) and 'KH domain-containing protein' (35.m00901, 136
peptide hits). The high number of peptide hits demonstrates
that these proteins are clearly present in high copy number
yet have little or no detectable mRNA; such proteins are inter-
esting candidates for understanding the relationship between
mRNA and protein abundance levels in Toxoplasma.
Figure 7c displays the comparison of the number of proteins
identified matching each quartile of genes, according to
mRNA expression level. There is a general trend for more
proteins to have been detected for genes with higher mRNA
expression levels (from the top quartile, 972 proteins have
The tachyzoite expressed proteome: comparison with EST and microarray expression data Figure 7
The tachyzoite expressed proteome: comparison with EST and microarray expression data. A comparison of the expressed proteome of tachyzoites with 
EST and microarray data reveals discrepancies between protein and transcriptional data. (a) Venn diagram comparing the correlation between the number 
of non-redundant release4 genes detected by EST expression from T. gondii tachyzoite and bradyzoites (available from ToxoDB) and those detected by this 
proteome study. The number of genes unique to each intersection is indicated. (b) Venn diagrams comparing the correlation between release4 genes 
obtained by this proteome study and those detected by microarray analysis of RH strain tachyzoites, including those genes with expression of ≥ 25 and ≥ 
50 percentiles. (c) Bar chart showing the number of release4 genes also detected by proteomics for each of the four percentile ranges, 0-24%, 25-49%, 50-
74%, 75-100%, determined by microarray analysis.
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been detected, and only 204 have been detected from the
bottom quartile), indicating, as expected, that there is some
correlation between mRNA abundance and protein
abundance.
Genome annotation and generation of a public 
proteome interface for Toxoplasma
The mass spectrometry data in this study were searched
against a database containing the current set of predicted pro-
teins from ToxoDB (referred to here as release4), predicted
proteins derived from alternative gene models (GLEAN,
TigrScan, TwinScan and Glimmer), ESTs and a translation of
all six ORFs (see Materials and methods). As such, the pro-
teome data can provide evidence that an alternative gene
model is the correct prediction, or that a gene has not been
predicted at all in the genome.
The release4 annotation available in ToxoDB release 4.2 was
provided by the Toxoplasma Genome Sequencing Project.
The proteome data have been aligned with release4 gene
annotations where possible for identified peptide sequences
that exactly match a protein predicted in the release4 set.
These peptides can be viewed in relation to the predicted
protein and the genomic region from which the sequence is
predicted to have been produced. The peptide identifications
can be viewed in the ToxoDB genome browser GBrowse by
selecting the option 'Mass Spec Peptides (Wastling, et al.)'.
This dataset comprises 2,252 rel e a s e 4  g e n e s .  I n  a d d i t i o n ,
identified peptides that are more likely to have arisen from a
translation of an alternative gene model have been aligned,
and can be viewed in GBrowse by selecting the option 'Mass
Spec Peptides (Alternative Models)'.
For the majority of annotated genes, integration of the
expressed peptide data has provided direct confirmation of
the correct prediction of ORFs and positioning of exon-intron
boundaries, including a large number of hitherto 'hypotheti-
cal proteins'. The further significance and importance of this
corroboratory evidence become more apparent when consid-
ering the minority of cases where the peptide expression data
are in conflict with the gene prediction algorithms.
Approximately 15% of the complete proteome dataset con-
sists of peptide hits to regions of the scaffold where there are
discrepancies with the new gene annotation and peptides
mapped more convincingly to alternative gene models or
ORFs (that is, 394 protein coding sequences). Of the 394
alternative gene models and ORFs detected, most are
described as 'hypothetical' with minimal information availa-
ble and were detected using MudPIT analysis. These hits can
be viewed at ToxoDB using the queries and tools option that
guides the user to a main menu page from which gene expres-
sion confirmation via mass spectrometry can be accessed.
The option of refining the search to a single or combination of
proteomic approaches, and of searching either annotated
genes or ORFs, is available. By adopting the GBrowse viewing
option, the user can examine in detail individual ORFs and
the integrated peptide sequence data.
An example is illustrated in Figure 8 of a region of the scaffold
where peptide evidence supports the presence of an
expressed ORF but the new prediction algorithm has not
assigned a gene in the corresponding region. Eleven peptides
map to TgGlmHMM_3355 and TgTigrScan_5280 but the
release4 annotation does not predict an exon in this region.
Additional peptides in this region map to exons of the neigh-
boring gene 46m.02877; however, these peptides could also
be assigned to the coding sequence of TgGlmHMM_3355
and/or TgTigrScan_5280. In this case, the peptide evidence
appears to indicate that gene 46m.02877 could have an incor-
rect start methionine and be missing an amino-terminal
exon.
In other cases, peptide identifications are able to identify
errors in the predicted reading frame or strand orientation as
illustrated in Figure 9. Here 12 peptides derived from 35 indi-
vidual spectra originating from both 1-DE and MudPIT
approaches provided matching hits to TgGlmHMM_1717,
TgTwinScan_4462 and TgGLEAN_7850, whereas the new
gene prediction algorithm (assigned 50.m05694) is predicted
to lie on the opposite strand and TgTigrScan_8273 uses a dif-
ferent reading frame. The various algorithms also differ in the
predictions of the length and number of exons, although pep-
tide evidence supports a single exon. In this example, the pep-
tide expression data have provided supporting evidence for
the correct reading frame and the large number of peptide
hits to one region only indicates that the gene is likely to com-
prise a single exon.
Other discrepancies involving the positioning of the exon-
intron boundaries exist and, in some cases, the alternative
gene annotation models such as TgGlmHMM, TgTigrScan,
TgTwinScan and TgGLEAN correlate more closely with the
co-ordinates of the peptide data. In Figure 10, 12 peptides
from MudPIT analysis map to a region of the scaffold (X:
3917326-3920484) that is annotated with gene 28.m00300,
comprising two exons. Five of the twelve peptides match the
second exon of gene 28.m00300. While it appears that pep-
tides match the scaffold in the region of 28.m00300 exon 1,
these peptides have been predicted from a different frame
translation. Of further note is that one peptide maps to the
predicted intron region of gene 28.m00300. Alternative gene
models vary considerably in this region of the scaffold in both
the number and positioning of the exons and all 12 peptides
only appear in TgGlmHMM_2666, which does not have an
intron at this location, providing evidence that this model is
most likely to be correct.
An important use of peptide identification is to confirm that
intron-exon (splice) boundaries have been correctly pre-
dicted; these are notoriously difficult to predict accurately in
genome sequence using informatics approaches alone. If ahttp://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.11
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peptide sequence spans an intron, matching regions from the
splice donor and acceptor of two exons, this provides strong
evidence that splicing has been correctly predicted for these
exons. In total, our study identified 2,477 intron spanning
peptides in the official release4 annotation, providing sup-
porting evidence that these splice sites have been correctly
predicted. In addition, peptides aligning across 421 splice
boundaries predicted from alternative gene models only have
been identified. This number is highly significant, as the iden-
tifications provide strong evidence that the alternative gene
model is correct for this region, allowing the genome annota-
tion to be improved. One example of a peptide spanning an
intron is shown in Figure 8, where peptides have been
identified that span an intron between exons predicted by
TwinScan and Glimmer only.
Discussion
Draft genomes now exist for the majority of clinically impor-
tant protozoa, including most Apicomplexa. Providing an
accurate interpretation of gene annotation and expression
from these genomes is essential to understanding the biology
of host-pathogen interactions and in gaining a better
understanding of the relationship between gene transcription
and protein expression. Of particular importance is an appre-
ciation of the limitations that transcriptional data alone place
on our interpretation of how pathogens respond as they
develop through different life-stages, or during key processes
such as invasion and establishment within their hosts. Such
an observation has potentially huge implications for expres-
sion profiling and for the reliance on microarray data to
describe changes in gene expression. In this paper we
describe how global proteomic data for T. gondii provides
Peptide evidence indicating an ORF where release4 annotation does not predict an ORF Figure 8
Peptide evidence indicating an ORF where release4 annotation does not predict an ORF. The position of ORF X-3-4725402-4726856 in the genome 
scaffold is indicated by a red line on the grey track at the top of the figure and this region is expanded below, the red triangle demarking the ORF length. 
Different gene annotation models are presented one above the other bellow the scaffold. Predicted exons are indicated as blue boxes, linked by zigzag 
lines to indicate the position of exon/intron boundaries. The predicted sequence for TgGlmHMM_3355 is shown as an insert; sequence for which there is 
matching peptide evidence is shown in red. The peptide that spans an intron-exon boundary is shown in purple. Peptides aligning with this region are 
shown in yellow and the detailed MS information for one is shown, including the predicted sequence. Peptides that align with the release4 or alternative 
gene annotations are indicated on different lines. ESTs are shown as dark blue or brown boxes.Genome Biology 2008, 9:R116
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important insights into both genome annotation and gene
expression in this model apicomplexan parasite.
P r o t e o m i c  d a t a  e n a b l e  u s  t o  u n d e r s t a n d  w h a t  i s  a c t u a l l y
expressed, as opposed to what might be, or has the potential
to be, expressed in an organism. In general, the functional
characterization and protein localization profile detected in
T. gondii in this study fits well with that of the rapidly divid-
ing and invasive tachyzoites, which would be expected to be
highly metabolically active, with gene expression, protein
synthesis, remodeling and degradation all necessary proc-
esses involved in active parasite cell division and required for
successful host cell invasion. A similar profile was recently
obtained for the expressed proteome of the invasive form of
Cryptosporidium [19]. Penetration and maintenance within
the host cell would require expression of many apical
organelle proteins involved in invasion (category: cell rescue,
defense and virulence), as has been observed for the invasive
stages of Plasmodium and Cryptosporidium [19,20,31]. In
agreement, 44 proteins were assigned to an apical organelle
location in Figure 5a. Recent work has also shown the recruit-
ment of host endoplasmic reticulum, mitochondria and net-
works of intimately proximal microtubules facilitating active
transport of host nutrients to the parasite [32-35]. Notably,
proteins involved in cellular transport are well represented,
with more than 200 expressed in this life cycle stage. A signif-
icant proportion of proteins falls into the broad category 'pro-
teins with binding functions', including proteins involved in
the cytoskeleton that are also required for motility, an impor-
tant function during invasion. Many proteins were also
detected that would be expected to be expressed at low or
temporal levels within the cell, such as those involved in cell
cycle control (641.m01576, 38.m00005) or signal transduc-
tion (65.m01199,  59.m06067,  55.m04992,  49.m05708,
50.m05649). This suggests that the sensitivity of our pro-
teomic analyses was high.
Perhaps most notable were the large number of proteins
(36%) for which no information is available and these pro-
teins are listed as unclassified. A similarly large proportion
(39%) of proteins with unknown function were detected in
just one life cycle stage (the sporozoites) of Cryptosporidium
by proteomic analysis [19] and in the proteome of four life
cycle stages of P. falciparum (that is, 51%) [20]. More than
Peptide evidence indicating alternative frame shift Figure 9
Peptide evidence indicating alternative frame shift. The position of ORF XII-4-5562689-5562144 in the genome scaffold is indicated by a red line on the 
grey track at the top of the figure and this region is expanded below, the red triangle demarking the ORF length. Predicted exons are indicated as red 
shaded boxes, linked by zigzag lines to indicate the position of exon/intron boundaries. Peptides aligning with this region are shown in yellow. The gene of 
interest with the release4 annotation (50.m05694) is highlighted in blue. Predicted sequences for this gene and the ORF and TgGlmHMM_1717 are shown 
as inserts. Sequence for which there is matching peptide evidence is shown in red. TgGlmHMM_1717 comprises several exons and the complete sequence 
is not given; the start methionine is shown in green. Mass spectrometric evidence for one peptide sequence derived by the 1-DE approach is shown.http://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.13
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half the predicted genes of Toxoplasma  are annotated as
'hypothetical' in the genome. In this analysis, around 800
genes annotated as 'hypothetical protein' were identified,
allowing these annotations to be updated to 'confirmed pro-
tein'. Functional analysis was also carried out on the 394
alternative gene models and ORFs and revealed a far greater
proportion of proteins for which a functional assignment
could not be determined (70% compared to 36%). This result
reflects the limited annotation available for alternative gene
models and ORFs, partially due to the short length of many of
these sequences and difficulties obtaining functional infor-
mation by sequence similarity search if the predicted ORF or
alternative gene models do not closely resemble the correct
gene sequence.
Toxoplasma has a complex life cycle comprising four addi-
tional life cycle stages not studied here: the infective sporo-
zoite, two sexual stages and the encysted bradyzoite. Many
house-keeping proteins will be common to all stages,
although the proportion of shared proteins is not currently
known. In this analysis, approximately one-third of the pre-
dicted number of release4 genes were detected in the pro-
teome of the tachyzoite, although it is important to remember
that these predicted genes will include stage-specific genes
not expressed in the tachyzoite stage, so the actual proportion
of proteins detected compared to those expected is likely to be
considerably higher, although how much higher is impossible
to determine at this stage. Whole cell proteome analysis of the
related apicomplexan parasite, Cryptosporidium parvum,
Peptide evidence indicating alternative exon positioning and sequence annotation Figure 10
Peptide evidence indicating alternative exon positioning and sequence annotation. The position of ORF X-1-3917326-3920484 in the genome scaffold is 
indicated by a red line on the grey track at the top of the figure and this region is expanded below, the red triangle demarking the ORF length. Predicted 
exons are indicated as blue boxes, linked by zigzag lines to indicate the position of exon/intron boundaries. Gene 28.m00300 is shown with two exons. 
ESTs are shown as dark blue or brown boxes. Peptides aligning with this region are shown in yellow. The predicted sequence for ORF X-1-3917326-
3920484 is shown as an insert and sequence that matches exon 2 of gene 28.m00300 is shown in blue. Sequence for which there is matching peptide 
evidence is shown in red. Purple lettering indicates the positioning of the 'intron-located' peptide, mass spectrometric evidence for which is shown in the 
right hand insert.Genome Biology 2008, 9:R116
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indicated expression of a similar proportion of the genome
from the infective sporozoite stage [19], and this parasite also
exhibits multiple life cycle stages. Whether the protein set
detected is close to the complete proteome of the life cycle
stage or limited by the detection levels of the mass spectro-
metric techniques is not yet clear. Previous microarray analy-
sis of sporozoites, gametocytes and blood stage life cycle
stages of Plasmodium indicated 35% of genes were shared
[36] whereas this figure decreased to 6% at the proteome level
[20,37]. It is likely that some of this discrepancy results from
technical limitations associated with detecting low abun-
dance proteins, although it is possible that post-transcrip-
tional regulation also plays a role. In Toxoplasma, analysis of
568 EST assemblies from three life cycle stages, tachyzoites,
bradyzoites and oocysts, indicated 16% of genes are stage-
specific and, hence, that a large proportion of the genes is
shared [5]. A similar figure of 18% was obtained via SAGE
analysis [6].
The comparison of the detected proteome with microarray
results also reveals some interesting discrepancies. Of the
least abundant 25% mRNA values, which would usually be
described as no measurable mRNA signal above baseline, 204
proteins are detected. In contrast, of the genes with most
abundant mRNA (top 25%, approximately 1,900 genes), only
half of these are detected by proteome analysis. The most
abundant proteins are likely to have been sampled preferen-
tially in this analysis, and as such, we can hypothesize that
m a n y  o f  t h e  g e n e s  e x p r e s s i n g  h i g h  m R N A  l e v e l s  d o  n o t
exhibit similarly high abundances of protein product.
Without an in-depth absolute quantitative study of the com-
plete Toxoplasma proteome, which is highly challenging with
current technology, these results should not be over-inter-
preted. However, it appears that there is a considerable
degree of control that regulates the level of protein abun-
dance, independent of the rate of transcription in tachyzoites.
Our proteome data have been integrated and aligned with the
genome sequence at ToxoDB. The interface provided enables
visual inspection of peptides matched to the most current (in
this case 'release4') gene models, as well as to alternative gene
models and ORFs. The facility to visualize and query peptide
data, in tandem with EST and microarray data, allows users
of ToxoDB to place confidence in particular gene assignments
and to explore those genes that are expressed in tachyzoites.
As demonstrated above, the proteome data will enable con-
tinued improvement in gene models through the confirma-
tion of the correct reading frame and intron-exon boundaries.
More fundamentally, the proteome analysis raises several
issues in relation to the correct determination of gene models.
Many gene prediction algorithms work on the basis of
sequence similarity to cDNA or protein sequence databases,
EST sequences or other genome sequences (where conserved
regions are more likely to correspond to genes). As such, gene
finders are relatively successful at identifying 'typical' genes
t h a t  a r e  s i m i l a r  t o  g e n e  s t r u c t u r e s  p r e v i o u s l y  o b s e r v e d  i n
other organisms. However, where genes are atypical in struc-
ture, or have no EST data, gene finding algorithms may miss
such sequences altogether. Large-scale proteome scans are
able to contribute significantly in this area, by demonstrating
peptide hits to regions of the genome where genes have only
been weakly predicted or missed completely. Others have
recently also recognized the value of so-called 'proteogenomic
annotation' of genomes [38-42]. As more proteome data are
produced, and querying algorithms improve, it is likely that
the majority of protein-coding genes expressed in Toxo-
plasma  will be confirmed by mass spectrometry based
evidence.
Conclusion
This study represents an unprecedented integration of pro-
teomic and genomic data for Toxoplasma, which we suggest
might serve as a model well beyond this present field. As well
as providing novel information on the functional aspects of
the proteome, our data demonstrate how proteomics can
inform gene predictions and help discover new genes. More-
over, the data reveal some surprising, but potentially highly
significant, discrepancies between protein expression and
transcript expression data as assessed by both EST analysis
and microarrays. We believe that this has important implica-
tions for how we interpret transcriptional expression data in
the Apicomplexa, such as that derived from microarray
experiments, and points to the fact that determining both
absolute protein expression and post-translational events will
be a key factor in gaining a more complete understanding of
the biology of these pathogenic organisms.
Materials and methods
Chemicals and materials
Chemicals were AnalaR or HPLC grade and from VWR
(Poole, UK) except: amidosulphobetaine-14 (ASB-14; Calbio-
chem, Nottingham, UK); deoxycholate (Sigma-Aldrich, Stein-
heim, Germany); iodoacetamide (Sigma-Aldrich); Invitrosol
(Invitrogen, Carlsbad, CA, USA); Mini complete protease
inhibitor cocktail (Roche, Penzberg, Germany); bovine pan-
creas sequencing grade trypsin (Roche); thiourea (Sigma-
Aldrich); TCEP (tris (2-carboxyethyl) phosphine hydrochlo-
ride (Pierce, Rockford, IL, USA); 2-DE consumables (Amer-
sham Biosciences, Little Chalfont, UK).
Parasite culture
Tachyzoites of T. gondii strain RH were maintained in conflu-
ent layers of Vero cells (ECACC, Salisbury, UK). T. gondii
tachyzoites were harvested 3 or 4 days post-infection as pre-
viously described [13].
One-dimensional PAGE analysis
A pellet of 1.1 × 108 tachyzoites (approximately 220 μg) was
solubilized in 40 μl of 100 mM Tris/HCl pH 6.8, 10% (v/v)
glycerol, 4% (w/v) SDS, 0.01% (w/v) Bromophenol Blue, 200http://genomebiology.com/2008/9/7/R116 Genome Biology 2008,     Volume 9, Issue 7, Article R116       Xia et al. R116.15
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mM dithiothreitol (DTT), with three cycles of 5 minutes at
90°C and 2 minutes vortexing, then spun at 16,000 g for 3
minutes. The supernatant was run on a 16 cm 12% (v/v) acry-
lamide gel using the denaturing Tris-glycine method of Lae-
mmli [43], at 16 mA for 30 minutes and 24 mA for 6-7 h at
15°C. The gel was stained with colloidal Coomassie blue, the
lane cut into 129 slices of < 1 mm thickness and each digested
with trypsin. For the Tris-fractionated sample, a pellet of 9.85
× 107 tachyzoites was solubilized on ice for 1 h in 50 μl of 100
mM Tris/HCl pH 8.5 and vortexed every 10 minutes. Three
cycles of freeze-thaw using liquid nitrogen, and 2 minutes of
vortexing followed, and the sample spun at 16,000 g at 4°C
for 30 minutes to partition Tris-soluble protein (supernatant)
from Tris-insoluble protein (pellet). The latter was further
solubilized in 50 μl of 2% (v/v) SDS, 100 mM DTT using three
cycles of 5 minutes at 90°C and 2 minutes vortexing, with a
final spin at 16,000 g for 15 minutes. An aliquot of 20 μl of 100
mM Tris/HCl pH 6.8, 10% (v/v) glycerol, 4% (w/v) SDS,
0.01% (w/v) Bromophenol Blue, 200 mM DTT was added to
30 μl of Tris-insoluble protein (approximately 130 μg), and to
30  μl of Tris-soluble protein (approximately 120 μg) and
resolved on a 12% (w/v) acrylamide gel as described above.
Twenty-five gel slices were excised from a region of the gel
deemed to exhibit maximum density and variation in protein
banding.
Two-dimensional PAGE analysis
Frozen pellets of T. gondii tachyzoites were solubilized in 7 M
urea, 2 M thiourea, 4% (w/v) Chaps, 2% (w/v) ASB14, 20 mM
Tris base, 60 mM DTT, 1 mM EDTA, 1 × Mini Complete pro-
tease cocktail inhibitor, 0.5% (v/v) immobilized pH gradient
(IPG) strips buffer (pH 4-7 linear gradient, 1 × 108 tach-
yzoites, approximately 200 μg; pH3-10 non-linear gradient,
2.58 × 108 tachyzoites, approximately 516 μg). The samples
were incubated at room temperature for 4-5 h with a vigorous
vortex every half an hour and spun at 16,000 g for 5 minutes.
The supernatants were made to a final volume of 450 μl with
8 M urea, 2% (w/v) CHAPS (3- [(3-cholamidopropyl)-
dimethylammonio]-1-propane  sulphonate),  0.002% (w/v)
Bromophenol Blue, 40 mM DTT, supplemented with 0.5%
(v/v) pH 3-10 NL or pH 4-7 L IPG buffer and used to rehy-
drate 24 cm Immobiline IPG strips for a minimum of 10 h at
room temperature. The rehydrated strips were placed on an
Ettan™ IPGphor II™ with a loading manifold (GE Health-
care, Bucks, UK) and isoelectric focusing (IEF) was run at
20°C, 75 μA per strip as follows: stepped voltage, 500 V for 2
h; gradient voltage, 1,000 V over 8 h; gradient voltage, 10,000
V over 3 h; stepped voltage, 10,000 V for 4 h and 15 minutes
(approximately 65, 000 Volt hours). The IPG strips were
equilibrated for 15 minutes each in 6 M urea, 50 mM Tris/
HCL pH 8.8, 30% (v/v) glycerol, 2% (w/v) SDS, 0.002% (w/
v) Bromophenol Blue supplemented with 1% (w/v) DTT, then
with 2.5% (w/v) iodoacetamide and mounted on DALT 12.5%
(w/v) pre-cast 24 cm acrylamide gels resolved using an Ettan
DALT™ 6-MultiTemp III apparatus and buffering kit
(Amersham Biosciences). Gels were run at 20°C, 3 W for 0.5
hour and 17 W per gel thereafter.
Colloidal Coomassie staining
Gels were fixed in 40% (v/v) ethanol, 10% (v/v) acetic acid
overnight at room temperature, rinsed in distilled deionized
water, stained for 5 days with colloidal Coomassie stain (20%
(v/v) methanol, 0.08% (w/v) CBB G250, 0.8% (v/v) phos-
phoric acid, 8% (w/v) ammonium sulfate), rinsed in distilled
deionized water and stored in 1% (v/v) acetic acid at 4°C.
In-gel tryptic digestion
Gel plugs/slices were destained at 37°C using 50 mM ammo-
nium bicarbonate/50% acetonitrile. One-dimensional gel
s l i c e s  w e r e  i n c u b a t e d  a t  3 7 ° C  w i t h  1 0  m M  D T T / 1 0 0  m M
ammonium bicarbonate for 30 minutes, then 100 mM iodoa-
cetamide/55 mM ammonium bicarbonate for 1 h in the dark.
Gel plugs/slices were dehydrated with 100% (v/v) acetonitrile
at 37°C and rehydrated at 37°C with 10 μl of 10 ng/μl sequenc-
ing grade trypsin in 25 mM ammonium bicarbonate. After 1
h, 25 mM ammonium bicarbonate was added to cover the gel
pieces, which were left at 37°C overnight. The reaction was
stopped with 2 μl of 2.6 M formic acid and the samples stored
at -20°C.
Tandem mass spectrometry (LC-MS/MS)
LC-MS/MS was performed on an LTQ ion-trap mass spec-
trometer (Thermo-Electron, Hemel Hempstead, UK) coupled
on-line to a Dionex Ultimate 3000 (Dionex Company,
Amsterdam, The Netherlands) HPLC system equipped with a
nano pepMap100 C18 RP column (75 μm; 3 μm, 100 Ang-
stroms) equilibrated in 98.9% water/2% acetonitrile/0.1%
(v/v) formic acid at 300 nl/minute. Tryptic peptides were
desalted on a C18 TRAP, and resolved with a linear gradient
of 0-50% (v/v) acetonitrile/0.1% (v/v) formic acid over 30
minutes, followed by 80% (v/v) acetonitrile/0.1% (v/v) for-
mic acid for 5 minutes. Ionized peptides were analyzed using
the 'triple play' mode (0-106 m/z, global and Msx), consisting
initially of a survey (MS) spectrum from which the three most
abundant ions were determined (threshold = 200-500 TIC
[total ion chromatogram]). The charge state of each ion was
assigned from the C13 isotope envelope 'zoom scan', frag-
mented (collision energy 35% for 30 ms) and subjected to a
MS/MS scan. The LTQ was tuned using a 500 fmol/μl solu-
tion of glufibrinopeptide (m/z 785.8, [M+2H]2+). The result-
ing MS/MS spectra were submitted to TurboSequest
Bioworks version 3.1 (Thermo Fisher Scientific Inc.,
Waltham, MA, USA) (threshold cut-off 0-1000; group scan
default 100; minimum group count 1; minimum ion count 15;
peptide tolerance 1.5), the individual spectra (dta files)
merged into an mgf file and submitted to Mascot (Matrix Sci-
ence, London, UK) and searched against a locally mounted
Toxoplasma genome database comprising ORFs > 50 amino
acids; clustered ESTs; whole genome shotgun (10×); TwinS-
can, TigrScan and GlimmerHMM protein predictions; and T.
gondii  annotated proteins_ToxoDB release 4.1. SearchGenome Biology 2008, 9:R116
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parameters were: fixed carbamidomethyl modification of
cysteine; variable oxidation of methionine; peptide tolerance
± 1.5 Da; MS/MS tolerance ± 0.8 Da; +1, +2, +3 peptide
charge state; single missed trypsin cleavage.
Manual validation of Mascot results
Additional manual validation of the proteins identified by
Mascot was carried out on the 1-DE and 2-DE results. Pro-
teins identifications that were based on a single peptide and
proteins that returned a Mascot score < 60 were accepted if:
a matching peptide possessed an individual ion score above
the significant threshold for identity or extensive homology
(typically > 44); or upon manual inspection of individual pep-
tide MS/MS spectra at least 60% of the candidate y-ions were
at a minimum signal to noise ratio of 10%. Spectra that failed
to pass either rule were regarded as false positive identifica-
tions, which can result from an accumulation of several pep-
tides with low ion scores.
Sample preparation for MudPIT
A pellet of 109 tachyzoites resuspended to approximately 800
μg/ml in 500 μl 100 mM Tris buffer pH 8.5 were lysed by
three cycles of freeze/thaw and the Tris-soluble and insoluble
protein fractions separated at 16,000 g for 30 minutes. Diges-
tion of soluble fractions: MS compatible detergent Invitrosol
was added to 1% (v/v), the solution heated to 60°C for 5 min-
utes, vortexed for 2 minutes, denatured with 2 M urea,
reduced with 5 mM Tris (2-carboxyethyl) phosphine hydro-
chloride (TCEP), carboxyamidomethylated with 10 mM
iodoacetamide, followed by addition of 1 mM CaCl2  and
trypsin at a ratio of 1:100 (enzyme:protein) and incubated at
37°C overnight. Digestion of insoluble fractions: 10% (v/v)
Invitrosol was added to the pellet, which was heated to 60°C
for 5 minutes, vortexed for 2 minutes and sonicated for 1 h.
The sample was diluted to 1% (v/v) Invitrosol with 8 M urea/
100 mM Tris/HCl pH 8.5, reduced and carboxyamidomethyl-
ated as before, and digested with endoproteinase Lys-C for 6
h. The solution was diluted to 4 M urea with 100 mM Tris/
HCl pH 8.5 and digested with trypsin as described above.
Mass spectrometric analysis by MudPIT
Five soluble replicates and four insoluble samples were each
subjected to MudPIT analysis with modifications to the
method of Link et al. [44], using a quaternary Agilent 1100
series HPLC coupled to a Finnigan LTQ-ion trap mass spec-
trometer (Thermo, San Jose, CA, USA) with a nano-LC elec-
trospray ionization source [45]. Peptide mixtures were
resolved by strong cation exchange LC upstream of reverse
phase LC as described [46]. Each sample (approximately 100
μg) was loaded onto separate microcolumns and resolved by
fully automated 12 step chromatography. Protein databases:
a Toxoplasma database was assembled (see above). To iden-
tify contaminant host proteins, the parasite database was
supplemented with a contaminant database (the complete
prokaryote and mammalian databases from NCBI). To esti-
mate the amount of false positives, a reverse database was
added [47]. Poor quality spectra were removed from the data-
set using an automated spectral quality assessment algorithm
[48]. Tandem mass spectra remaining after filtering were
searched with the SEQUEST algorithm version 27 [49]. All
searches were in parallel and were performed on a Beowulf
computer cluster consisting of 100 1.2 GHz Athlon CPUs [50].
No enzyme specificity was considered for any search.
SEQUEST results were assembled and filtered using the
DTASelect (version 2.0) program [51], which uses a quadratic
discriminate analysis to dynamically set XCorr and DeltaCN
thresholds for the entire dataset to achieve a user-specified
false positive rate (< 5% peptides false positive in this analy-
sis). The false positive rates are estimated by the program
from the number and quality of spectral matches to the decoy
database.
Bioinformatics prediction
Prediction programs used were: SignalP to predict proteins
that contain signal peptides; TMHMM to predict
transmembrane domains; results returned from PATS, Plas-
Mit, and WoLF PSORT together with release4 gene descrip-
tion and GO cellular component prediction provided by
T o x o D B  w e r e  c o m b i n e d  t o  o b t a i n  s u b c e l l u l a r  l o c a l i z a t i o n
prediction of proteins.
Mapping of proteome data to the genome scaffold
Peptides that hit release4 gene annotation could be directly
mounted upon the ToxoDB genome scaffold. Where the data-
base search identified preferentially an alternative gene
model or an ORF, the sequences were mapped onto the
genome using the following algorithm: rule 1, if all the pep-
tides from the alternative models could be mapped to a
release4 gene, the release4 annotation is adopted and this is
t e r m e d  a  1 0 0 %  m a t c h ;  r u l e  2 ,  i f  m o r e  t h a n  5 0 %  o f  t h e
peptides from an alternative model can be mapped to an offi-
cial release4 gene, this is considered a valid mapping and the
matching peptides are aligned with the corresponding
release4 gene; rule 3, if a certain set of peptides from an alter-
native model can be mapped to more than one release4 gene,
the gene that can host most peptides will be reported; rule 4,
alternative models not conforming to rule 2 will then be
mapped to ORFs; rule 5, an alternative model will be mapped
to an ORF only if 100% of the peptides can be mapped to that
ORF. If 100% of the peptides from the alternative model can-
not be mapped to a single release4 gene (rule 1) or to a single
ORF (rule 5), the peptides are also mapped to the alternative
gene model (for example, TgTwinscan, TgGLEAN, and so on),
which can be viewed in GBrowse by selecting the relevant
option. This enables ToxoDB users to directly visualize pro-
teomics evidence for alternative gene annotation. All raw data
associated with this manuscript may now be downloaded
from the Tranche Project [52], using the following hash: Ulv/
yTYTaaHin5Tv4InpsgoUY1uTJQtdoLRi9HbdtypXqztv+BiV
E/wZieBkqu6d3kU20Vyejo0HYCfswgwiGyPHQPAAAAAAA
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Additional data files
The following additional data are available with the online
version of this paper. Data files 1 and 2 are 2-DE gel images
showing the spot numbering system that accompanies Fig-
ures 1 and 2. Additional data files 3 and 4 are tables listing the
MS data and protein identifications corresponding to Figures
1 and 2. Additional data files 5 and 8 are tables listing the MS
data and protein identifications (redundant and non-redun-
dant, respectively) for the 1-DE separation illustrated in Fig-
ure 3. Additional data file 6 is a 1-DE gel image of Tris-
fractionated proteins, and Additional data files 7 and 9 are
tables listing the corresponding MS data and protein identifi-
cations (redundant and non-redundant, respectively). Addi-
tional data files 10 and 11 are tables listing the MS data and
redundant protein identifications for soluble and insoluble
phase proteins analyzed by MudPIT. Additional data files 12
and 13 are tables listing the protein identifiers corresponding
to Figure 5a, b. Additional data file 14 is a pie chart illustrating
functional categories for alternative gene models and ORFs.
Additional data file 1 Detailed 2-DE proteome map (pH 3-10) of T. gondii tachyzoite  proteins Soluble proteins from 2.53 × 108 tachyzoites (516 μg protein)  resolved by IEF over a narrow linear pH 3-10 range followed by  molecular mass on a 12.5% (w/v) acrylamide gel under denaturing  conditions. Protein spots are visualized using colloidal Coomassie.  Individual spots are numbered and the corresponding mass spec- trometric data are detailed in Additional data file 3. Click here for file Additional data file 2 Detailed 2-DE proteome map (pH 4-7) of T. gondii tachyzoite  proteins Soluble proteins from 1 × 108 tachyzoites (200 μg protein) resolved  by IEF over a narrow linear pH 4-7 range followed by molecular  mass on a 12.5% (w/v) acrylamide gel under denaturing conditions.  Protein spots are visualized using colloidal Coomassie. Individual  spots are numbered and the corresponding mass spectrometric  data are detailed in Additional data file 4. Click here for file Additional data file 3 MS evidence obtained from 2-DE proteome map (pH 3-10) of T.  gondii tachyzoite proteins The spot number, matching gene annotation and description, Mas- cot score, sequence coverage and number of matching peptides are  given. Further information concerning peptide sequences is availa- ble at ToxoDB. For consistency, where the release4 annotation is  not identified by the peptide evidence, TwinScan gene annotation  is given in preference to other alternative gene annotations assum- ing the returning Mascot score is equivalent (and in Additional data  files 4, 5, 7, 8 and 9). Click here for file Additional data file 4 MS evidence obtained from 2-DE proteome map (pH 4-7) of T.  gondii tachyzoite proteins The spot number, matching gene annotation and description, Mas- cot score, sequence coverage and number of matching peptides are  given. Further information concerning peptide sequences is availa- ble at ToxoDB. For consistency, where the release4 annotation is  not identified by the peptide evidence, TwinScan gene annotation  is given in preference to other alternative gene annotations assum- ing the returning Mascot score is equivalent. Click here for file Additional data file 5 MS evidence comprising all (redundant) proteins identified using  the 1-DE approach Listed in the columns (from left to right) are: the gel slice number,  ranking of each protein hit returned from the Mascot search for  that gel slice, corresponding gene annotations and descriptions,  Mascot scores, number of matching peptides to each protein and  sequence coverage. Further information concerning peptide  sequences is available at ToxoDB. For consistency, where the  release4 annotation is not identified by the peptide evidence, Twin- Scan gene annotation is given in preference to other alternative  gene annotations assuming the returning Mascot score is  equivalent. Click here for file Additional data file 6 Tris-fractionated tachyzoite proteins resolved by 1-DE SDS-soluble proteins from 9.85 × 107 tachyzoites previously frac- tionated into Tris-soluble (120 μg) and Tris-insoluble (130 μg) frac- tions were resolved on a 12% (w/v) acrylamide gel under  denaturing conditions as follows: protein standards (lane 1), Tris- insoluble protein (lane 2) and Tris-soluble protein (lane 4). Pro- teins were visualized using colloidal Coomassie. The masses of the  protein standards and the position of every gel slice are shown. Click here for file Additional data file 7 MS evidence comprising all (redundant) proteins identified using  the Tris fractionated 1-DE approach Listed in the columns (from left to right) are: the gel slice number,  ranking of each protein hit returned from the Mascot search for  that gel slice, corresponding gene annotations and descriptions,  Mascot scores, number of matching peptides to each protein and  sequence coverage. Further information concerning peptide  sequences is available at ToxoDB. For consistency, where the  release4 annotation is not identified by the peptide evidence, Twin- Scan gene annotation is given in preference to other alternative  gene annotations assuming the returning Mascot score is  equivalent. Click here for file Additional data file 8 MS evidence comprising the complete list of non-redundant pro- teins identified using 1-DE approach Listed in the columns (from left to right) are: the gene annotations  and descriptions of each protein, the highest individual Mascot  score, sequence coverage and number of matching peptides  returned for that protein from all the gel slices in which it appeared,  and the gel slice number that this refers to. Individual peptide  amino acid sequence, MS scores and a measure of the total  sequence coverage obtained is available at ToxoDB. For consist- ency, where the release4 annotation is not identified by the peptide  evidence, TwinScan gene annotation is given in preference to other  alternative gene annotations assuming the returning Mascot score  is equivalent. Click here for file Additional data file 9 MS evidence comprising all the non-redundant proteins identified  using the Tris fractionated 1-DE approach Listed in the columns (from left to right) are: the gene annotations  and descriptions of each protein, the highest individual Mascot  score, sequence coverage and number of matching peptides  returned for that protein from all the gel slices in which it appeared,  and the gel slice number that this refers to. Individual peptide  amino acid sequence, MS scores and a measure of the total  sequence coverage obtained is available at ToxoDB. For consist- ency, where the release4 annotation is not identified by the peptide  evidence, TwinScan gene annotation is given in preference to other  alternative gene annotations assuming the returning Mascot score  is equivalent. Click here for file Additional data file 10 MS evidence comprising all (redundant) proteins identified from  the soluble MudPIT fraction The unprocessed results from MudPIT analysis lists: gene annota- tions and descriptions for each protein; alternative gene annotation  for that region of the scaffold; total Xcorr scores for each protein  hit; individual Xcorr scores theoretical mass and pI values and  sequences for each individual matching peptide. Click here for file Additional data file 11 MS evidence comprising all (redundant) proteins identified from  the insoluble MudPIT fraction The unprocessed results from MudPIT analysis lists: gene annota- tions and descriptions for each protein; alternative gene annotation  for that region of the scaffold; total Xcorr scores for each protein  hit; individual Xcorr scores theoretical mass and pI values and  sequences for each individual matching peptide. Click here for file Additional data file 12 Subcellular localization categorization of the expressed tachyzoite  proteome (from Figure 5a) List of protein identifiers according to subcellular localization cat- egory. Number of non-redundant proteins is shown in brackets. Click here for file Additional data file 13 Functional categorization of the expressed tachyzoite proteome  (from Figure 5b) List of protein identifiers according to functional category. Number  of non-redundant proteins is shown in brackets. Click here for file Additional data file 14 Functional categorization of the expressed tachyzoite proteome  comprising alternative gene models and ORFs The amino acid sequences of alternative genes and ORFs were sub- mitted to BlastP and results returning e-values < e-30 were consid- ered. Homology to apicomplexan proteins was prioritized when  deciding the protein description to be used to assist the assignment  of functional category. Sequences returning no significant BlastP  result or with a description 'hypothetical protein' were searched  against Amigo Blast [54] to determine the potential GO classifica- tion. The same e-value cut-off was applied. The above information  was then used in conjunction with InterPro and independent liter- ature searches to assign a MIPS category within the FunCatDB  functional catalogue. Note: protein fate includes protein folding,  modification and destination. Click here for file
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